Arti Dhar Selected Research

eIF-2 Kinase (eIF 2 Kinase)

9/2021	Inhibition of double stranded RNA dependent protein kinase (PKR) abrogates isoproterenol induced myocardial ischemia in vitro in cultured cardiomyocytes and in vivo in wistar rats.
1/2021	High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats.
12/2020	PKR inhibitor imoxin prevents hypertension, endothelial dysfunction and cardiac and vascular remodelling in L-NAME-treated rats.
11/2020	Up-regulation of PKR pathway contributes to L-NAME induced hypertension and renal damage.
1/2019	Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arti Dhar Research Topics

Disease

10	Inflammation (Inflammations) 09/2021 - 01/2016
8	Hypertension (High Blood Pressure) 01/2022 - 09/2008
8	Insulin Resistance 09/2021 - 05/2014
5	Fibrosis (Cirrhosis) 01/2022 - 01/2020
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
4	Obesity 06/2018 - 01/2013
2	Hypertrophy 04/2022 - 01/2020
2	Neoplasms (Cancer) 02/2022 - 10/2021
2	Glucose Intolerance 03/2011 - 01/2010
1	COVID-19 03/2022
1	Mouth Neoplasms (Oral Cancer) 02/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Acute Pain 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2021
1	Necrosis 09/2021
1	Infections 01/2020
1	Vascular Calcification 01/2020
1	Diabetic Cardiomyopathies 06/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2017
1	Metabolic Diseases (Metabolic Disease) 06/2017
1	Prediabetic State (Prediabetes) 05/2014
1	Stroke (Strokes) 05/2014
1	Body Weight (Weight, Body) 06/2007
1	Weight Gain 06/2007

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2011
7	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2021 - 01/2017
6	Protein Kinases (Protein Kinase)IBA 09/2021 - 01/2017
5	eIF-2 Kinase (eIF 2 Kinase)IBA 09/2021 - 01/2019
4	Eosine Yellowish-(YS) (Eosin)IBA 04/2022 - 01/2020
4	Pyruvaldehyde (Methylglyoxal)IBA 03/2011 - 09/2008
3	FructoseIBA 01/2021 - 05/2014
2	Analgesics (Analgesic Drugs)IBA 03/2022 - 01/2022
2	Advanced Glycation End ProductsIBA 09/2021 - 09/2008
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2020
2	Insulin (Novolin)FDA Link 01/2021 - 03/2011
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2020 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2008
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2018 - 01/2017
2	CarbohydratesIBA 01/2013 - 03/2011
1	Gentian Violet (Violet, Crystal)FDA Link 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	AntipyreticsIBA 03/2022
1	Pharmaceutical PreparationsIBA 02/2022
1	Fluorouracil (Carac)FDA LinkGeneric 02/2022
1	HydrogelsIBA 02/2022
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2022
1	Etodolac (Lodine)FDA LinkGeneric 02/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Chloroform (Trichloromethane)IBA 10/2021
1	PhytochemicalsIBA 10/2021
1	Phosphotransferases (Kinase)IBA 09/2021
1	Mitogen-Activated Protein KinasesIBA 09/2021
1	JNK Mitogen-Activated Protein KinasesIBA 09/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Sweetening Agents (Sweeteners)IBA 01/2021
1	imoxinIBA 12/2020
1	CollagenIBA 11/2020
1	Bromodeoxyuridine (BrdU)IBA 01/2020
1	alizarinIBA 01/2020
1	Sepharose (Agarose)IBA 01/2020
1	CytokinesIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2019
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2019
1	Prion ProteinsIBA 05/2014
1	Tyrosine (L-Tyrosine)FDA Link 05/2014
1	Serine (L-Serine)FDA Link 05/2014
1	Insulin ReceptorIBA 05/2014
1	High Fructose Corn SyrupIBA 01/2013
1	Sucrose (Saccharose)IBA 01/2013
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 03/2011
1	Vasodilator Agents (Vasodilators)IBA 01/2011
1	GasotransmittersIBA 01/2011
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2011
1	alagebriumIBA 01/2010
1	Rosiglitazone (Avandia)FDA Link 06/2007
1	ThiazolidinedionesIBA 06/2007
1	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2007
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 06/2007
1	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2007

Therapy/Procedure

3	Therapeutics 09/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 02/2022